Table 1.
Relationship between miR-34a expression and clinicopathological features in EHCC patients
| Clinicopathological features | n | miR-34a | P value | |
|---|---|---|---|---|
| Low | High | |||
| Age (yr) | 0.695 | |||
| <60 | 14 | 4 | 10 | |
| ≥60 | 13 | 5 | 8 | |
| Gender | 1.000 | |||
| Male | 16 | 8 | 8 | |
| Female | 11 | 6 | 5 | |
| Tumor size (cm) | 0.449 | |||
| <2 | 12 | 5 | 7 | |
| ≥2 | 15 | 9 | 6 | |
| Pathological type | 0.222 | |||
| Adenocarcinoma | 24 | 11 | 13 | |
| Mucocellulare carcinoma | 0 | 0 | 0 | |
| Adenosquamous carcinoma | 3 | 3 | 0 | |
| Squamous carcinoma | 0 | 0 | 0 | |
| Undifferentiated carcinoma | 0 | 0 | 0 | |
| Cell differentiation | 0.326 | |||
| Well | 4 | 3 | 1 | |
| Moderately | 8 | 5 | 3 | |
| Poorly | 15 | 8 | 7 | |
| Bismuth classification | 0.385 | |||
| Bismuth I | 7 | 1 | 6 | |
| Bismuth II | 13 | 10 | 3 | |
| Bismuth III | 6 | 2 | 4 | |
| Bismuth IV | 1 | 1 | 0 | |
| Lymphatic node metastasis | 0.004 | |||
| Absent | 9 | 1 | 8 | |
| Present | 18 | 13 | 5 | |
| Clinical stages | <0.001 | |||
| I + II | 13 | 2 | 11 | |
| III + IV | 14 | 12 | 2 | |
P <0.05 is significant